294 related articles for article (PubMed ID: 34805165)
1. Identification and Validation of the Pyroptosis-Related Molecular Subtypes of Lung Adenocarcinoma by Bioinformatics and Machine Learning.
Liu LP; Lu L; Zhao QQ; Kou QJ; Jiang ZZ; Gui R; Luo YW; Zhao QY
Front Cell Dev Biol; 2021; 9():756340. PubMed ID: 34805165
[TBL] [Abstract][Full Text] [Related]
2. Risk factors analysis and survival prediction model establishment of patients with lung adenocarcinoma based on different pyroptosis-related gene subtypes.
Wen Z; Pei B; Dai L; Lu P; Li X; Zhang C; Ge S
Eur J Med Res; 2023 Dec; 28(1):601. PubMed ID: 38111060
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of pyroptosis-related factors in lung adenocarcinoma.
Lin X; Zhou T; Hu S; Yang L; Yang Z; Pang H; Zhou X; Zhong R; Fang X; Yu Z; Hu K
J Thorac Dis; 2022 Mar; 14(3):654-667. PubMed ID: 35399245
[TBL] [Abstract][Full Text] [Related]
4. Investigating subtypes of lung adenocarcinoma by oxidative stress and immunotherapy related genes.
Duan G; Huang C; Zhao J; Zhang Y; Zhao W; Dai H
Sci Rep; 2023 Nov; 13(1):20930. PubMed ID: 38017020
[TBL] [Abstract][Full Text] [Related]
5. Identification of a Five Autophagy Subtype-Related Gene Expression Pattern for Improving the Prognosis of Lung Adenocarcinoma.
Zhang MY; Huo C; Liu JY; Shi ZE; Zhang WD; Qu JJ; Yue YL; Qu YQ
Front Cell Dev Biol; 2021; 9():756911. PubMed ID: 34869345
[No Abstract] [Full Text] [Related]
6. Molecular clustering based on gene set expression and its relationship with prognosis in patients with lung adenocarcinoma.
Xing B; Shi L; Bao Z; Liang Y; Liu B; Liu R
J Thorac Dis; 2022 May; 14(5):1638-1650. PubMed ID: 35693605
[TBL] [Abstract][Full Text] [Related]
7. A Pyroptosis-Related Signature Predicts Overall Survival and Immunotherapy Responses in Lung Adenocarcinoma.
Zhu K; Yan A; Zhou F; Zhao S; Ning J; Yao L; Shang D; Chen L
Front Genet; 2022; 13():891301. PubMed ID: 35795208
[No Abstract] [Full Text] [Related]
8. Identification of a Pyroptosis-Related Gene Signature for Predicting the Immune Status and Prognosis in Lung Adenocarcinoma.
Gong Z; Li Q; Yang J; Zhang P; Sun W; Ren Q; Tang J; Wang W; Gong H; Li J
Front Bioeng Biotechnol; 2022; 10():852734. PubMed ID: 35646872
[No Abstract] [Full Text] [Related]
9. Identification of a Pyroptosis-Related Gene Signature for Prediction of Overall Survival in Lung Adenocarcinoma.
Dong Z; Bian L; Wang M; Wang L; Wang Y
J Oncol; 2021; 2021():6365459. PubMed ID: 34630565
[TBL] [Abstract][Full Text] [Related]
10. Constructing novel molecular subtypes and an 11-gene signature based on pyroptosis signaling for lung adenocarcinoma.
Li L; He Q; Tao Z; Zhang R; Cui Y; Qian L
Am J Cancer Res; 2022; 12(7):3051-3066. PubMed ID: 35968341
[TBL] [Abstract][Full Text] [Related]
11. Exploring hub pyroptosis-related genes, molecular subtypes, and potential drugs in ankylosing spondylitis by comprehensive bioinformatics analysis and molecular docking.
Li X; Li X; Wang H; Zhao X
BMC Musculoskelet Disord; 2023 Jun; 24(1):532. PubMed ID: 37386410
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma.
Tian Q; Zhou Y; Zhu L; Gao H; Yang J
Front Cell Dev Biol; 2021; 9():684259. PubMed ID: 34307361
[No Abstract] [Full Text] [Related]
13. A pyroptosis-related gene model and its correlation with the microenvironment of lung adenocarcinoma: A bioinformatics analysis and experimental verification.
Dong Y; Yi L; Song Q; Yao Y
Front Genet; 2022; 13():997319. PubMed ID: 36437954
[No Abstract] [Full Text] [Related]
14. A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies.
Li Y; Ge D; Gu J; Xu F; Zhu Q; Lu C
BMC Cancer; 2019 Sep; 19(1):886. PubMed ID: 31488089
[TBL] [Abstract][Full Text] [Related]
15. Identification of four metabolic subtypes and key prognostic markers in lung adenocarcinoma based on glycolytic and glutaminolytic pathways.
Zhang J; Wang X; Song C; Li Q
BMC Cancer; 2023 Feb; 23(1):152. PubMed ID: 36782138
[TBL] [Abstract][Full Text] [Related]
16. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
[TBL] [Abstract][Full Text] [Related]
17. Identification of a Sixteen-gene Prognostic Biomarker for Lung Adenocarcinoma Using a Machine Learning Method.
Ma B; Geng Y; Meng F; Yan G; Song F
J Cancer; 2020; 11(5):1288-1298. PubMed ID: 31956375
[No Abstract] [Full Text] [Related]
18. Identification of a novel gene expression signature associated with overall survival in patients with lung adenocarcinoma: A comprehensive analysis based on TCGA and GEO databases.
Zhao J; Guo C; Ma Z; Liu H; Yang C; Li S
Lung Cancer; 2020 Nov; 149():90-96. PubMed ID: 33002836
[TBL] [Abstract][Full Text] [Related]
19. The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformatics.
Ni KW; Sun GZ
Math Biosci Eng; 2019 Aug; 16(6):7671-7687. PubMed ID: 31698633
[TBL] [Abstract][Full Text] [Related]
20. Homologous recombination repair rathway and RAD54L in early-stage lung adenocarcinoma.
Zheng S; Yao L; Li F; Huang L; Yu Y; Lin Z; Li H; Xia J; Lanuti M; Zhou H
PeerJ; 2021; 9():e10680. PubMed ID: 33628633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
